Elevance Health Reports Results for Fourth Quarter and Full Year 2023; Sets Full Year 2024 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Elevance Health Inc. (ELV) Reports In-Line Q4 EPS, Beats on Revenue; Offers Guidance
January 24, 2024 6:03 AM ESTElevance Health Inc. (NYSE: ELV) reported Q4 EPS of $5.62, in-line with the analyst estimate of $5.62. Revenue for the quarter came in at $42.5 billion versus the consensus estimate of $42.22 billion.
Projected FY 2024 GAAP diluted EPS and adjusted diluted EPS2 of greater than $34.29 and $37.10 per share,... More
